1.Efficacy of laparoscopic radical cystectomy with indocyanine green fluorescence imaging versus standard lymph node dissection: a randomized comparative study
Lifeng LIU ; Na CAO ; Yansong GUO ; Hao WANG ; Xiaopeng WANG ; Fengshuo YANG ; Yuepeng HU ; Longjiang TIAN ; Dawei TIAN
Journal of Modern Urology 2025;30(3):212-214
Objective: To investigate the efficacy,safety and feasibility of regional lymph node dissection in laparoscopic radical surgery for bladder cancer under the guidance of indocyanine green fluorescence imaging. Methods: A total of 30 patients with muscle invasive bladder cancer (T2/T3NxM0) who volunteered to enter the clinical trial were randomly divided into the indocyanine green imaging guided laparoscopic regional lymph node dissection group (n=15) and the standard pelvic lymph node dissection group (n=15).The number of positive lymph nodes,operation time,intraoperative bleeding volume,incidence of lymph leakage,and tumor recurrence and metastasis rate 2-year after surgery were collected. Results: The number of positive lymph nodes was (4.20±1.66) and (4.60±1.72) respectively in the indocyanine green and standard groups,with no statistically significant difference (P>0.05).There were no statistically significant difference in the tumor recurrence and metastasis rates 2-year after surgery between the two groups (P>0.05).However,the indocyanine green group had shorter operation time,less intraoperative bleeding volume,and lower incidence of lymphatic leakage than the standard group (P<0.05). Conclusion: Indocyanine green fluorescence imaging guided laparoscopic lymph node dissection has comparable clinical efficacy to standard lymph node dissection,but with fewer complications.
2.Treatment of antibody-drug conjugates in elderly patients
Basic & Clinical Medicine 2025;45(10):1270-1276
Antibody-drug conjugates(ADCs)are emerging anti-cancer drugs that have been widely applied in the treatment of hematological and solid tumors.ADCs deliver cytotoxic drugs to tumor cells with precision through anti-body targeting,enhancing efficacy while reducing side effects.Elderly cancer patients face treatment challenges due to factors such as drug metabolism,multiple comorbidities and decreased physical function.However,ADCs have therapeutic advantages in elderly patients.The article discusses the efficacy,safety,dosing strategies,and adverse reaction management of ADCs in elderly patients,in order to provide effective and safe treatment options for elderly cancer patients.
3.Application of indocyanine green fluorescence imaging in the precise dissection of lymph nodes during laparoscopic radical resection of bladder cancer
Lifeng LIU ; Yansong GUO ; Hao WANG ; Xiaopeng WANG ; Fengshuo YANG ; Yuepeng HU ; Longjiang TIAN
Journal of Modern Urology 2024;29(7):638-641
Objective To investigate the efficacy,safety and feasibility of laparoscopic lymph node dissection guided by indocyanine green(ICG)fluorescence imaging.Methods A total of 30 patients with muscle-invasive bladder cancer(MIBC,T2/T3NxM0)who were admitled to the Cangzhou People's Hospital during Mar.2018 and Jun.2022 were included.The lymph nodes were cleared with ICG fluorescence imaging first,and then the remaining lymph nodes were cleared according to the standard pelvic lymph node range.The lymph node positive rate of ICG fluorescence imaging guided laparoscopic lymph node precise dissection and standard pelvic lymph node dissection was analyzed by self-comparison.Results ICG fluorescence imaging guided laparoscopic lymph node precise dissection needed shorter operation time than standard pelvic lymph node dissection[(21.80±6.80)min vs.(47.70±10.73)min,P<0.05].There was no significant difference in the lymph node positive rate between the two approaches[(11.34±9.06)%vs.(12.36±9.43)%,P>0.05],but the former approach caused less damage on blood vessels and nerves.Conclusion Indocyanine green fluorescence imaging guided laparoscopic lymph node dissection has comparable efficacy to standard pelvic lymph node dissection,which can reduce ineffective lymph node dissection,shorten the operation time,and reduce the risk of complications.
4.Immunological function variation of peripheral dendritic cell from bladder cancer patients after blocking PD-L1 pathway
Xing LIU ; Dengke YANG ; Keqin ZHANG ; Yanfeng LI ; Yao ZHANG ; Fengshuo JIN
Chinese Journal of Urology 2013;(2):126-129
Objective To investigate the immunological function variation of peripheral dendritic cell(DC)from bladder cancer patients after blocking PD-L1 pathway.Methods DC from normal control and patient with bladder cancer were cultured with rhGM-CSF,rhIL-4 in vitro and treated with PD-L1 monoclonal antibody.The expression of CD1a,HLA and CD83 were examined by flow cell meter.The effect of DC induced lymphatic cellular proliferation and its capability of secreting IL-10,IL-12 were determined by MTT and ELISA.Results Blocking PD-LI pathway did not infuluence the maturation of DC.But the DCs from bladder cancer patient signifcantly boosted the lymphatic cellular proliferating(4.00 ± 1.28 versus 1.49 ±0.45)and IL-12 secretion capability(108.30 ± 21.89 versus 37.17 ± 14.89 ng/L),and yet it also decreased the secretion of IL-10(108.90 ± 21.77 versus 14.99 ± 54.99 ng/L)after blocking PD-L1 pathway (P < 0.05).Conclusion Blocking PD-LI pathway on the DC from bladder cancer patient may improve its anticancer immunological function.

Result Analysis
Print
Save
E-mail